SMC
ICUI icon

Smith, Moore & Co’s ICU Medical ICUI Stock Holding History

Smith, Moore & Co’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-810
Closed -$204K – 321
2019
Q2 		$204K Buy
+810
New +$188K 0.05% 301
2019
Q1 		– Sell
-1,104
Closed -$254K – 335
2018
Q4 		$254K Buy
+1,104
New +$272K 0.07% 263

Other funds holding ICUI

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NC
Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Smith, Moore & Co's ICUI Position: Q3 2019 in Review

Smith, Moore & Co sold out of ICU Medical (ICUI) in Q3 2019, closing a stake of 810 shares — an estimated $204K sold.

Smith, Moore & Co first reported a position in ICUI in Q4 2018 and held it in 2 quarters. The position peaked at $254K in Q4 2018. 260 funds tracked by Wall St. Rank hold ICUI as of Q3 2019.

  • Smith, Moore & Co reported no remaining ICU Medical position as of Q3 2019 after selling out during the quarter.
  • Smith, Moore & Co sold 810 ICU Medical shares in Q3 2019, an estimated $204K.
  • Smith, Moore & Co first reported a position in ICU Medical in Q4 2018 and held it in 2 quarters.
  • Smith, Moore & Co's ICU Medical position peaked at $254K in Q4 2018.
  • 260 funds tracked by Wall St. Rank held ICU Medical as of Q3 2019.

Based on Smith, Moore & Co's 13F filing for Q3 2019, filed 7 Nov 2019.